Date of Award

2025

Degree Type

Thesis

Degree Name

Master of Science in Interdisciplinary Neurosciences

Department

Interdisciplinary Neuroscience

First Advisor

Daniel Roxbury

Abstract

Single-walled carbon nanotubes (SWCNTs) possess unique physicochemical and optical properties that make them ideal candidates for biomedical imaging, biosensing, and disease diagnostics. This thesis explores the potential of SWCNT-based spectral fingerprinting combined with ML (Machine Learning) algorithms to optimize bioimaging, disease detection and prediction, with a specific focus on differentiating between healthy and amyotrophic lateral sclerosis (ALS) lymphoblastic patient samples. By functionalizing SWCNTs with single-stranded DNA, we enhance their stability and target specificity, enabling their application in serum patient samples.

A comprehensive spectral analysis of DNA-SWCNTs was conducted using near-infrared fluorescence spectroscopy and other characterization techniques, including UV-Vis-absorption spectroscopy. The spectral data obtained from healthy and ALS serum samples were processed using mathematical approaches, statistic methods and advanced ML algorithms to establish a nanotube spectral fingerprint, facilitating precise disease characterization and classification.

This work highlights the advantage of integrating SWCNT-based nanotechnology with computational methodologies to develop a novel, non-invasive specific diagnostic tool. The study demonstrates high sensitivity and specificity in differentiating healthy and ALS patient serum lymphoblast samples, paving the way for enhanced early-stage neurological diagnostics. Furthermore, the findings contribute to the broader of nano biosensors and their applications in personalized medicine and point of care diagnostics.

The successful implementation of this approach could revolutionize bioimaging and sensing techniques, providing a rapid, reliable, and cost-effective platform for early disease detection and monitoring. Future research will focus on refining the SWCNT functionalization by expanding the sensors to different DNA strands, varying the processing of data and ML models, expanding the sample size, and investigating additional biomarker features to further validate and test the technique’s clinical applicability for different neurological diseases.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.